Covista and Other Small-Cap Stocks in Focus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 5 days ago
0mins
Source: CNBC
- Small-Cap Investment Opportunity: John Rogers of Ariel Investments highlighted Covista as a for-profit education company focused on training doctors and nurses, addressing the global shortage in these professions, which is expected to drive future growth for the company.
- Market Volatility Insight: Rogers noted that the current AI craze is causing significant short-term volatility in the market, suggesting that the overall market is overvalued and value investors are facing challenges, reminiscent of the conditions leading up to the internet bubble burst.
- Financial Services Outlook: He pointed to Lazard and Carlyle Group as financial stocks worth watching in the current macroeconomic backdrop, despite their respective declines of 16% and 29% this year, indicating that there are still investment opportunities in undervalued stocks, particularly with Lazard's strong management team.
- Strong Performance of Small-Caps: Rogers also mentioned that other Chicago-based small-cap stocks like Littelfuse and Knowles have surged approximately 89% and 90% this year, respectively, highlighting the robust performance of small-cap stocks in the current market environment, which is attracting investor interest.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CVSA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CVSA
Wall Street analysts forecast CVSA stock price to rise
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 124.660
Low
Averages
High
Current: 124.660
Low
Averages
High
About CVSA
Covista Inc., formerly Adtalem Global Education Inc., is a healthcare educator serving across five accredited institutions. Its institutions include American University of the Caribbean School of Medicine, Chamberlain University, Ross University School of Medicine, Ross University School of Veterinary Medicine and Walden University. It provides personalized, tech-enabled access to healthcare careers. Its American University of the Caribbean School of Medicine provides medical education with a focus on clinical experience across its two campuses in Sint Maarten and Preston, United Kingdom. Chamberlain University is an educator for nursing students in the United States, offering nursing and healthcare programs at over 24 campuses nationwide and online. Walden University provides healthcare education for working professionals through a range of online programs which include nursing, health sciences, public health and healthcare leadership.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Covista and Advocate Health Collaborate to Expand Nursing Education Access
- New Nursing Education Model: Covista's collaboration with Advocate Health provides scholarships, clinical experience, and loan repayment support through Chamberlain University, aiming to create direct employment pathways for hundreds of students annually, effectively addressing the nursing workforce shortage in the U.S.
- Strategic Talent Development: The initiative focuses on nontraditional students, particularly working adults, combining clinical education with employment opportunities, with recruitment expected to begin next month for classes starting in September, reflecting a deep understanding and response to community nursing needs.
- Market Demand Response: Covista's Care Capacity Monitor indicates over 702,000 healthcare job openings each month, with 306,000 unemployed healthcare workers available to fill them, highlighting the widening gap in nursing talent and the importance of collaboration between education and healthcare systems.
- Commitment to Sustainability: Advocate Health reinvests over $6 billion annually to improve community health, and through its partnership with Covista, establishes a community-rooted pathway for nursing talent development, ensuring that the next generation of nurses can meet the demands of complex clinical environments.
See More
Covista and Other Small-Cap Stocks in Focus
- Small-Cap Investment Opportunity: John Rogers of Ariel Investments highlighted Covista as a for-profit education company focused on training doctors and nurses, addressing the global shortage in these professions, which is expected to drive future growth for the company.
- Market Volatility Insight: Rogers noted that the current AI craze is causing significant short-term volatility in the market, suggesting that the overall market is overvalued and value investors are facing challenges, reminiscent of the conditions leading up to the internet bubble burst.
- Financial Services Outlook: He pointed to Lazard and Carlyle Group as financial stocks worth watching in the current macroeconomic backdrop, despite their respective declines of 16% and 29% this year, indicating that there are still investment opportunities in undervalued stocks, particularly with Lazard's strong management team.
- Strong Performance of Small-Caps: Rogers also mentioned that other Chicago-based small-cap stocks like Littelfuse and Knowles have surged approximately 89% and 90% this year, respectively, highlighting the robust performance of small-cap stocks in the current market environment, which is attracting investor interest.
See More
Covista Executive's Share Sale Raises Eyebrows
- Executive Sell-Off: Covista's CEO Stephen W. Beard sold 5,291 shares on June 10 and 11, 2026, totaling approximately $690,000, reducing his direct holdings to 424,033 shares, which are valued at about $55.9 million post-sale.
- Ownership Impact: This sale accounted for 1.23% of Beard's direct ownership, significantly lower than his previous trade of 15,874 shares in May 2026, indicating a potential shift in his holding strategy and a cautious outlook on the company's future.
- Transaction Context: The sale was executed under Covista's stock ownership policy, where Beard is not required to sell shares exceeding minimum holding requirements, and it was part of a trading plan established in December 2025, suggesting that the sale may not reflect a negative sentiment towards the company.
- Investor Considerations: While insider sales do not always indicate bearish sentiment, Beard's recent sell-off is noteworthy, especially as it occurs near CVSA's 8-month high, prompting investors to carefully assess the implications for the company's future performance.
See More
Covista Executive's Share Sale Raises Concerns
- Executive Share Sale: Covista's CEO Stephen W. Beard sold 5,291 shares on June 10 and 11, 2026, for approximately $690,000, reducing his direct holdings by 1.23%, which indicates a cautious outlook on the company's future.
- Trading Plan Context: The sale was executed under a trading plan established in December 2025, as Covista prohibits discretionary trades by executives, suggesting that the sale may not reflect a negative view of the company, yet it raises market concerns.
- Change in Holdings: Post-sale, Beard's direct holdings decreased to 424,033 shares with no indirect ownership remaining, although he still holds over $55 million in Covista equity, highlighting his significant stake in the company's performance.
- Market Reaction and Investment Advice: While insider sales do not necessarily indicate a bleak outlook, investors should approach this information with caution, especially given that Covista was not recommended by The Motley Fool Stock Advisor, which could influence investment decisions.
See More
Analysis of Three Stocks Capturing Wall Street's Attention
- Covista's Dismal Outlook: Covista (CVSA) has shown a lackluster annual revenue growth of only 15.2% over the past five years, indicating a loss of competitive ground, with a projected 3.8 percentage point decline in free cash flow margin next year reflecting increased investments to defend its market position; the current stock price of $123.04 implies a forward P/E ratio of 14.4x, suggesting potential overvaluation.
- Merit Medical's Challenges: Merit Medical Systems (MMSI) has a modest revenue base of $1.54 billion, which limits its fixed cost leverage and distribution channels, resulting in below-average returns on capital; trading at $60.64 per share with a forward P/E of 14.8x indicates management's struggle to find compelling investment opportunities.
- Ally Financial's Growth Struggles: Ally Financial (ALLY) has experienced a mere 2.7% annual revenue growth over the past two years, significantly slower than its financial peers, and despite revenue growth, its earnings per share have declined by 4.8% annually; with a high net-debt-to-EBITDA ratio of 8x, the company may face challenges raising capital under unfavorable terms, trading at $40.99 per share with a forward P/E of 7.5x, indicating financial health concerns.
- Market Environment Shift: The rapid market changes are accelerating the separation of quality stocks from overvalued ones, with AI technologies swiftly impacting various sectors, prompting investors to stay alert to market dynamics to identify potential investment opportunities.
See More
Covista Surpasses Q1 Expectations with Strong Enrollment Growth
- Strong Performance: Covista reported Q1 revenue of $487 million, exceeding analyst expectations of $474 million, reflecting a 4.5% year-on-year growth that underscores the company's robust market performance and growth potential.
- Adjusted EPS Beat: The adjusted EPS came in at $1.98, surpassing the analyst estimate of $1.72 by 14.9%, indicating effective cost control and profitability strategies within the company.
- Enrollment Growth Driver: Significant enrollment growth at Chamberlain and Walden universities was highlighted, with CEO Stephen Beard noting a return to positive total enrollment at Chamberlain, demonstrating the effectiveness of operational improvements.
- Guidance Upgraded: Management raised its full-year revenue guidance to $1.94 billion and adjusted EPS guidance to $8.05, reflecting confidence in future performance and an optimistic outlook on market conditions.
See More
Covista and Advocate Health Collaborate to Expand Nursing Education Access
- New Nursing Education Model: Covista's collaboration with Advocate Health provides scholarships, clinical experience, and loan repayment support through Chamberlain University, aiming to create direct employment pathways for hundreds of students annually, effectively addressing the nursing workforce shortage in the U.S.
- Strategic Talent Development: The initiative focuses on nontraditional students, particularly working adults, combining clinical education with employment opportunities, with recruitment expected to begin next month for classes starting in September, reflecting a deep understanding and response to community nursing needs.
- Market Demand Response: Covista's Care Capacity Monitor indicates over 702,000 healthcare job openings each month, with 306,000 unemployed healthcare workers available to fill them, highlighting the widening gap in nursing talent and the importance of collaboration between education and healthcare systems.
- Commitment to Sustainability: Advocate Health reinvests over $6 billion annually to improve community health, and through its partnership with Covista, establishes a community-rooted pathway for nursing talent development, ensuring that the next generation of nurses can meet the demands of complex clinical environments.
See More
Covista and Other Small-Cap Stocks in Focus
- Small-Cap Investment Opportunity: John Rogers of Ariel Investments highlighted Covista as a for-profit education company focused on training doctors and nurses, addressing the global shortage in these professions, which is expected to drive future growth for the company.
- Market Volatility Insight: Rogers noted that the current AI craze is causing significant short-term volatility in the market, suggesting that the overall market is overvalued and value investors are facing challenges, reminiscent of the conditions leading up to the internet bubble burst.
- Financial Services Outlook: He pointed to Lazard and Carlyle Group as financial stocks worth watching in the current macroeconomic backdrop, despite their respective declines of 16% and 29% this year, indicating that there are still investment opportunities in undervalued stocks, particularly with Lazard's strong management team.
- Strong Performance of Small-Caps: Rogers also mentioned that other Chicago-based small-cap stocks like Littelfuse and Knowles have surged approximately 89% and 90% this year, respectively, highlighting the robust performance of small-cap stocks in the current market environment, which is attracting investor interest.
See More
Covista Executive's Share Sale Raises Eyebrows
- Executive Sell-Off: Covista's CEO Stephen W. Beard sold 5,291 shares on June 10 and 11, 2026, totaling approximately $690,000, reducing his direct holdings to 424,033 shares, which are valued at about $55.9 million post-sale.
- Ownership Impact: This sale accounted for 1.23% of Beard's direct ownership, significantly lower than his previous trade of 15,874 shares in May 2026, indicating a potential shift in his holding strategy and a cautious outlook on the company's future.
- Transaction Context: The sale was executed under Covista's stock ownership policy, where Beard is not required to sell shares exceeding minimum holding requirements, and it was part of a trading plan established in December 2025, suggesting that the sale may not reflect a negative sentiment towards the company.
- Investor Considerations: While insider sales do not always indicate bearish sentiment, Beard's recent sell-off is noteworthy, especially as it occurs near CVSA's 8-month high, prompting investors to carefully assess the implications for the company's future performance.
See More
Covista Executive's Share Sale Raises Concerns
- Executive Share Sale: Covista's CEO Stephen W. Beard sold 5,291 shares on June 10 and 11, 2026, for approximately $690,000, reducing his direct holdings by 1.23%, which indicates a cautious outlook on the company's future.
- Trading Plan Context: The sale was executed under a trading plan established in December 2025, as Covista prohibits discretionary trades by executives, suggesting that the sale may not reflect a negative view of the company, yet it raises market concerns.
- Change in Holdings: Post-sale, Beard's direct holdings decreased to 424,033 shares with no indirect ownership remaining, although he still holds over $55 million in Covista equity, highlighting his significant stake in the company's performance.
- Market Reaction and Investment Advice: While insider sales do not necessarily indicate a bleak outlook, investors should approach this information with caution, especially given that Covista was not recommended by The Motley Fool Stock Advisor, which could influence investment decisions.
See More
Analysis of Three Stocks Capturing Wall Street's Attention
- Covista's Dismal Outlook: Covista (CVSA) has shown a lackluster annual revenue growth of only 15.2% over the past five years, indicating a loss of competitive ground, with a projected 3.8 percentage point decline in free cash flow margin next year reflecting increased investments to defend its market position; the current stock price of $123.04 implies a forward P/E ratio of 14.4x, suggesting potential overvaluation.
- Merit Medical's Challenges: Merit Medical Systems (MMSI) has a modest revenue base of $1.54 billion, which limits its fixed cost leverage and distribution channels, resulting in below-average returns on capital; trading at $60.64 per share with a forward P/E of 14.8x indicates management's struggle to find compelling investment opportunities.
- Ally Financial's Growth Struggles: Ally Financial (ALLY) has experienced a mere 2.7% annual revenue growth over the past two years, significantly slower than its financial peers, and despite revenue growth, its earnings per share have declined by 4.8% annually; with a high net-debt-to-EBITDA ratio of 8x, the company may face challenges raising capital under unfavorable terms, trading at $40.99 per share with a forward P/E of 7.5x, indicating financial health concerns.
- Market Environment Shift: The rapid market changes are accelerating the separation of quality stocks from overvalued ones, with AI technologies swiftly impacting various sectors, prompting investors to stay alert to market dynamics to identify potential investment opportunities.
See More
Covista Surpasses Q1 Expectations with Strong Enrollment Growth
- Strong Performance: Covista reported Q1 revenue of $487 million, exceeding analyst expectations of $474 million, reflecting a 4.5% year-on-year growth that underscores the company's robust market performance and growth potential.
- Adjusted EPS Beat: The adjusted EPS came in at $1.98, surpassing the analyst estimate of $1.72 by 14.9%, indicating effective cost control and profitability strategies within the company.
- Enrollment Growth Driver: Significant enrollment growth at Chamberlain and Walden universities was highlighted, with CEO Stephen Beard noting a return to positive total enrollment at Chamberlain, demonstrating the effectiveness of operational improvements.
- Guidance Upgraded: Management raised its full-year revenue guidance to $1.94 billion and adjusted EPS guidance to $8.05, reflecting confidence in future performance and an optimistic outlook on market conditions.
See More
